Nebacumab’s demise leaves door wide open for other sepsis therapies Diana FauldsGill Higgins Newsletter Article 14 February 2013 Pages: 3 - 4
Mini-antibodies - solving problems of size and penetration Ian Mundell Newsletter Article 14 February 2013 Pages: 6 - 7
Pyrazinoylguanidine - an attractive candidate for controlling hypertension Newsletter Article 14 February 2013 Pages: 9 - 9
Combination improves antitumour efficacy in liver metastases Newsletter Article 14 February 2013 Pages: 9 - 9
Fenretinide offers hope for prostate cancer prevention Gill Higgins Newsletter Article 14 February 2013 Pages: 10 - 10
Linsidomine compares favourably with isosorbide dinitrate Newsletter Article 14 February 2013 Pages: 10 - 10
A closer look at adjunctive therapy used with thrombolytics Newsletter Article 14 February 2013 Pages: 12 - 12
New recommendations for PCP prophylaxis from the US Newsletter Article 14 February 2013 Pages: 12 - 13
Thromboembolic prophylaxis not recommended in epoetin recipients Newsletter Article 14 February 2013 Pages: 15 - 15